The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 332:1163-1164 April 27, 1995 Number 17
NextNext

Survival of Dopaminergic Neurons in Fetal-Tissue Grafts

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The possibility of implanting tissue in the brains of patients with Parkinson's disease to alleviate motor deficits has been the focus of multiple international research efforts for the past several years and has generated much public interest. The initial optimism about the clinical benefit of autologous implants in the adrenal medulla was based on moderate clinical improvements reported in the Journal in 1987.1 This optimism diminished when the results of subsequent studies proved to be inconsistent and showed limited survival of the grafted material. Meanwhile, data from animals with motor abnormalities similar to those that occur in patients with Parkinson's . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.